PerkinElmer (PKI) has reported second-quarter results that surpassed the Street’s expectations, driven by impressive growth in revenues during the quarter. The company provides solutions to diagnostics, life science, food, and applied markets. Quarterly revenues came in at $1.23 billion, which surpassed the estimates of $1.12 billion, and increased 51% from $812 million a year ago. Growth was witnessed in the company’s Discovery & Analytical Solutions and Diagnostics segments. The company reported adjusted earnings of $2.83 per share, higher than $2.42 per share estimated by analysts. Notably, it compares favorably with $1.57 recorded in the same quarter last year.
https://www.tipranks.com/news/perkinelmer-reports-upbeat-q2-results-signs-deal-to-acquire-biolegend?utm_source=advfn.com&utm_medium=referral
PerkinElmer (NYSE:PKI)
Historical Stock Chart
From Oct 2021 to Nov 2021 Click Here for more PerkinElmer Charts.
PerkinElmer (NYSE:PKI)
Historical Stock Chart
From Nov 2020 to Nov 2021 Click Here for more PerkinElmer Charts.